Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
---|---|---|---|---|---|---|---|---|
ELV | ELEVANCE HEALTH INC | 1.27% | 141,500 | $66,725,740 | 141,500 | New | $471.56 | 13F |
QTTB | Q32 Bio Inc. | 0.74% | 2,252,987 | $37,512,234 | 2,252,987 | New | 13D | |
AVBP | ArriVent Biopharma, Inc. | 0.52% | 1,513,664 | $27,245,952 | 1,513,664 | New | Form 4 | |
ALNY | ALNYLAM PHARMACEUTICALS INC | 0.29% | 79,400 | $15,197,954 | 79,400 | New | $191.41 | 13F |
PFE | PFIZER INC (Call) | 0.27% | 500,000 | $14,395,000 | 500,000 | New | $28.79 | 13F |
KRYS | KRYSTAL BIOTECH INC | 0.24% | 103,700 | $12,865,022 | 103,700 | New | $124.06 | 13F |
FOLD | AMICUS THERAPEUTICS INC | 0.22% | 806,000 | $11,437,140 | 806,000 | New | $14.19 | 13F |
DXCM | DEXCOM INC | 0.17% | 73,200 | $9,083,388 | 73,200 | New | $124.09 | 13F |
ILMN | ILLUMINA INC | 0.08% | 30,300 | $4,218,972 | 30,300 | New | $139.24 | 13F |
AMAM | AMBRX BIOPHARMA INC | 0.08% | 296,000 | $4,215,040 | 296,000 | New | $14.24 | 13F |
RCUS | ARCUS BIOSCIENCES INC | 0.04% | 117,000 | $2,234,700 | 117,000 | New | $19.1 | 13F |
CLDX | CELLDEX THERAPEUTICS INC NEW | 0.04% | 58,800 | $2,332,008 | 58,800 | New | $39.66 | 13F |
FATE | FATE THERAPEUTICS INC | 0.04% | 528,080 | $1,975,019 | 528,080 | New | $3.74 | 13F |
TXG | 10X GENOMICS INC | 0.04% | 39,800 | $2,227,208 | 39,800 | New | $55.96 | 13F |
AGIO | AGIOS PHARMACEUTICALS INC | 0.02% | 45,000 | $1,002,150 | 45,000 | New | $22.27 | 13F |
GERN | GERON CORP | 0.02% | 485,000 | $1,023,350 | 485,000 | New | $2.11 | 13F |
VIR | VIR BIOTECHNOLOGY INC | 0.02% | 101,000 | $1,016,060 | 101,000 | New | $10.06 | 13F |